National Institute of Allergy and Infectious Diseases
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

Biodefense and Related Programs
 Biodefense
  About
  For Researchers
   Introduction
   Category A-C Pathogens
   Immunology of Biodefense
   Resources
   Funding
    FY2003 Awards
    FY2004 Awards
    FY2005 Awards
    FY2006 Awards
    FY2007 Awards
   Meetings
  Public and Media
 Radiation Countermeasures
 Chemical Countermeasures



Biodefense

Development of Therapeutic Agents for Selected Bacterial Diseases—FY2007 Awards

Institution Title
Elusys Development of Anthim a Monoclonal Antibody for the Treatment of Inhalational Anthrax
Emergent Development of Human Anthrax Immune Globulin
Nanotherapeutics Inhaled Gentamicin Dry-Powder Formulation for Postexposure Prophylaxis and Treatment of Aerosolized Pneumonic Plague and Tularemia
Pharmathene Development of Valortim a Human Monoclonal Antibody for the Treatment of Inhalational Anthrax